02.06.2016

Ceva Santé Animale has purchased Biovac Laboratories, a leading French manufacturer of autogeneous (bacterial) vaccines.
Biovac, like Ceva, has experienced double-digit growth for several years as veterinarians seek alternatives to control bacterial conditions often now difficult to treat with “classic” vaccines.  The company has significant expertise in microbiology, allowing it to provide custom-made solutions for veterinarians and their customers.
Ceva already offers custom vaccines to leading poultry and swine producers in other parts of the world.